Quanterix Corporation
NASDAQ:QTRXMedical - Devices
+$0.46 today
- Market cap
- $98.28M
- Beta
- 1.12
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$2.22
Volume 3.54M
Average 1.15M
QTRX Total Debt
Short-term and long-term borrowings combined.
Quanterix CorporationNASDAQ: QTRX
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt falls 2.9% from a year ago
Total debt stood at $35.34M at the end of Q1 FY2026, down 2.9% from a year earlier and down 5.1% from the prior quarter. Over 3 fiscal years it compounded at -5.5% a year.
Context
- Total debt amounted to 9.6% of total assets at the end of Q1 FY2026, up 0.5 pp from a year earlier.
- Total debt increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total debt keeps falling in the next quarterly balance sheet after a -2.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 37.24M USD
- Year-over-year change
- -0.4%
- 4-year CAGR
- +14.2%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 37.24M | -0.4% |
| FY2024 | 2024-12-31 | 37.37M | -9.9% |
| FY2023 | 2023-12-31 | 41.46M | -6.0% |
| FY2022 | 2022-12-31 | 44.1M | +101.5% |
| FY2021 | 2021-12-31 | 21.89M | — |
Total Debt vs competitors
How QTRX compares with its peers on the latest reported figures
- QTRX's Mar 2026 total debt of $35.34M is the 6th highest of the 11 companies compared; the peer median is $31.96M.
- Its year-over-year change of -2.9% is the 9th highest of 11, against a peer median of +5.2%.
- Total debt amounts to 9.6% of total assets for QTRX, versus a peer median of 22.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $3.73B | +91265.7% | -7.6% | 1.7% | |
| Mar 2026 | $101.61M | +3.5% | -0.6% | 40.7% | |
| Mar 2026 | $59.4M | +17.8% | +92.8% | 59.6% | |
| Mar 2026 | $43.14M | +5.0% | -18.1% | 41.9% | |
| Mar 2026 | $41.76M | +3.2% | +5.2% | 38.1% | |
| Mar 2026 | $35.34M | -2.9% | -5.5% | 9.6% | |
| Mar 2026 | $22.16M | -17.5% | -16.2% | 59.7% | |
| Mar 2026 | $16.94M | -11.9% | -9.1% | 5.9% | |
| Mar 2026 | $12.44M | +84.0% | +184.3% | 6.3% | |
| Dec 2025 | $7.85M | +5.4% | +19.3% | 4.8% | |
| Mar 2026 | $4.47M | +18.6% | -5.0% | 2.4% | |
| Peer median (excluding QTRX) | $31.96M | +5.2% | -2.8% | 22.2% | |
Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 396.47M | 338.74M | 174.42M | 56.71M | 29.84M |
| Short-term Investments | 0 | 0 | 146.9M | 232.41M | 88.39M |
| Net Receivables | 23.79M | 19.02M | 25.41M | 32.14M | 29.97M |
| Inventory | 22.19M | 16.96M | 26.12M | 32.78M | 54.76M |
| Other Current Assets | 6.51M | 6.8M | 9.23M | 9.56M | 9.29M |
| Total Current Assets | 448.96M | 381.52M | 382.1M | 363.59M | 212.26M |
| Property, Plant & Equipment (Net) | 29.45M | 41.03M | 36.18M | 33.49M | 40.34M |
| Goodwill | 9.63M | 0 | 0 | 0 | 26.38M |
| Intangible Assets | 10.53M | 7.52M | 6.03M | 4.03M | 131.79M |
| Long-term Investments | 2.58M | 2.6M | 0 | 0 | 0 |
| Tax Assets | 4.99M | 7.77M | 0 | 0 | 0 |
| Other Non-current Assets | 378K | (6.86M) | 4.26M | 5.42M | 8.01M |
| Total Non-current Assets | 57.56M | 52.06M | 46.47M | 42.94M | 206.51M |
| Total Assets | 506.51M | 433.58M | 428.57M | 406.53M | 418.77M |
| Account Payables | 9.21M | 3.84M | 5.05M | 6.95M | 13.57M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 822K | 1.02M | 0 |
| Deferred Revenue | 6.36M | 8.64M | 9.47M | 8.83M | 20.73M |
| Other Current Liabilities | 13.49M | 11.04M | 14.17M | 12.62M | 21.85M |
| Total Current Liabilities | 36.98M | 31.35M | 38.98M | 42.01M | 74.76M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 7.02M | 9.24M | 1.18M | 800K | 8.1M |
| Deferred Revenue (Non-current) | 1.1M | 1.42M | 1.23M | 1.07M | 5.83M |
| Other Non-current Liabilities | 0 | (7.77M) | 0 | 0 | 5.02M |
| Total Non-current Liabilities | 28.59M | 44.3M | 39.63M | 34.49M | 48.27M |
| Total Liabilities | 65.56M | 75.65M | 78.61M | 76.5M | 123.04M |
| Common Stock | 37K | 37K | 38K | 39K | 47K |
| Retained Earnings | (305.46M) | (403.2M) | (431.55M) | (470.08M) | (577.23M) |
| Accumulated OCI | 441K | (2.54M) | (1.67M) | (3.08M) | (723K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 440.95M | 357.93M | 349.96M | 330.04M | 295.73M |
| Total Debt | 21.89M | 44.1M | 41.46M | 37.37M | 37.24M |
| Net Debt | (374.57M) | (294.64M) | (132.96M) | (19.34M) | 7.4M |
Quanterix Corporation
NASDAQ:QTRX
Intrinsic Alpha fair value
Locked
Current Price
$2.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.